Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer Release Date: | Education | Oncology | USA | |
Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era Release Date: | Research | Vaccines | Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of | |
The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE Release Date: | Research | Hospital | China, Hong Kong | |
COVID-19 Disease Burden on the High Risk Population Release Date: | Education | Vaccines | All | |
New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease Release Date: | Research | Inflammation & Immunology | USA | |
Actionable Biomarker and Genetic Testing in Cancer: Education for Advanced Practice Providers (APPs) Release Date: | Education | Oncology | USA | |
Unmet Needs and Emerging Data in Patients with High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) | Education | Oncology | USA | |
Interdisciplinary Collaboration for the Management of Severe Alopecia Areata in Patients with Comorbidities Release Date: | Education | Inflammation & Immunology | USA | |
Antimicrobial Stewardship in the Sub-Saharan African Region Release Date: Partner: International Society for Infectious Diseases | Quality Improvement | Inflammation & Immunology | All | |
Enhancing Patient-Centered Outcomes in Emergency Department Migraine Management Release Date: Partner: American College of Emergency Physicians (ACEP) | Quality Improvement | Internal Medicine | USA | |
Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC) Release Date: | Education | Oncology | USA |
Title | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Emerging Mechanisms of Action in the Treatment of Moderate-to-Severe Atopic Dermatitis Release Date: | Education | Inflammation & Immunology | All | |
Pharmacist Education in Biosimilars (Western Europe, Canada, Japan) Release Date: | Education | Oncology | All | |
Biosimilars in Hematologic Malignancies & Supportive Care Release Date: | Education | Oncology | All | |
The Burden and Origins of Co-Infections in COVID-19 Pneumonia (Europe) Release Date: | Education | Hospital | All | |
Needs Assessment – Early Therapy Management with CDK 4/6 Inhibitors in Metastatic Breast Cancer Release Date: | Education | Oncology | USA | |
Advances in Atopic Dermatitis for Advanced Practitioners Release Date: | Education | Inflammation & Immunology | USA | |
2020 RD US- Next Generation PET Imaging for ATTR-CM | Research | Rare Disease | USA | |
Cardiac Transthyretin Amyloid (ATTR) Fellowship Competitive Grant Program Release Date: Partner: International Society of Amyloidosis | Fellowship | Rare Disease | All | |
Management of Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists Release Date: | Education | Inflammation & Immunology | USA | |
Pfizer and Mayo Clinic/Global Bridges–Providing Access to Learning Resources for Tobacco Dependence Treatment | Education | Internal Medicine | China, Malaysia, Taiwan, Thailand | |
4th Quality Improvement initiatives optimizing AF and VTE management in Canada | Quality Improvement | Internal Medicine | Canada | |
2021 Rheumatology Competitive Grant Program Release Date: | Research | Inflammation & Immunology | USA |